Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBeijing Tongren Hospital

About this trial

Hypertension, diabetes mellitus, and dyslipidemia are common internal diseases, and all diseases are atherosclerosis risk factors. Previous studies applied color fundus photography to analyze retinal vascular changes (including exudation, hemorrhage, neovascularization, etc.) in patients with hypertension or diabetes, but the examination results could not be quantified.

This study intends to apply optical coherence tomography angiography (OCTA) to examine retinal vessels. This method has the following advantages: 1) It can quantify vascular changes, and 2) It is noninvasive and reproducible for patients' follow-up.

This study was designed to investigate retinal vascular changes in patients with hypertension, diabetes, and dyslipidemia on OCTA. We will collect the patients' general information (gender, age), comorbidities, medications, blood lipids, blood glucose, carotid ultrasound, ankle-brachial index, ambulatory blood pressure monitoring, color fundus photography, and OCTA results. We will follow up with the patients for five years and conduct the mentioned examinations once a year. We will also investigate the correlation between systemic atherosclerosis (such as coronary artery stenosis, and carotid artery stenosis) and retinal vasculopathy in patients with these diseases.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with hypertension

Or patients with diabetes

Or patients with dyslipidemia

Agree to participate in this study

Disqualifiers

Patients with malignant tumors

Patients with autoimmune diseases

Patients with immunodeficiency disease

Disagree to participate in this study

Trial population

Patients in the geriatric department of Beijing Tongren Hospital, China. Beijing Tongren Hospital is a third-class hospital.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • No intervention

    Other intervention

    No intervention

Treatment groups

300 Participants
are divided into 3 treatment groups
Group A: Hypertension1 intervention
Group B: Diabetes mellitus1 intervention
Group C: Dyslipidemia1 intervention

Trial outcomes

Primary outcomes

1

Vascular density of the retina

percent

Time frame
up to 5 years of follow-up.

Secondary outcomes

1

the foveal avascular zone (FAZ) size of the retina

mm2

Time frame
When participating in the study, and once a year during 5 years of follow-up.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.